Two Sigma Investments
ACER

Two Sigma Investments’s Acer Therapeutics Inc ACER Stock Holding History

Two Sigma Investments’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18,091
Closed -$13.7K – 3383
2023
Q1 		$13.7K Buy
+18,091
New +$35.7K ﹤0.01% 2876
2021
Q1 		– Sell
-12,872
Closed -$34K – 4350
2020
Q4 		$34K Buy
+12,872
New +$34.6K ﹤0.01% 3264
2020
Q1 		– Sell
-21,042
Closed -$84K – 3991
2019
Q4 		$84K Sell
21,042
-13,907
-40% -$47.3K ﹤0.01% 3541
2019
Q3 		$111K Buy
34,949
+8,672
+33% +$25.4K ﹤0.01% 3296
2019
Q2 		$102K Buy
+26,277
New +$501K ﹤0.01% 3199
2018
Q4 		– Sell
-15,634
Closed -$482K – 3654
2018
Q3 		$482K Buy
+15,634
New +$419K ﹤0.01% 2478

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's ACER Position: Q2 2023 in Review

Two Sigma Investments sold out of Acer Therapeutics Inc (ACER) in Q2 2023, closing a stake of 18,091 shares — an estimated $13.7K sold.

Two Sigma Investments first reported a position in ACER in Q3 2018 and held it in 6 quarters. The position peaked at $482K in Q3 2018. 28 funds tracked by Wall St. Rank hold ACER as of Q2 2023.

  • Two Sigma Investments reported no remaining Acer Therapeutics Inc position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 18,091 Acer Therapeutics Inc shares in Q2 2023, an estimated $13.7K.
  • Two Sigma Investments first reported a position in Acer Therapeutics Inc in Q3 2018 and held it in 6 quarters.
  • Two Sigma Investments's Acer Therapeutics Inc position peaked at $482K in Q3 2018.
  • 28 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.